CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index; 30 of the 114 sources its claims cite were checked for support.
Abstract
p21Waf/CIP1 is a small unstructured protein that binds and inactivates cyclin-dependent kinases (CDKs). To this end, p21 levels increase following the activation of the p53 tumor suppressor. CDK inhibition by p21 triggers cell-cycle arrest in the G1 and G2 phases of the cell cycle. In the absence of exogenous insults causing replication stress, only residual p21 levels are prevalent that are insufficient to inhibit CDKs. However, research from different laboratories has demonstrated that these residual p21 levels in the S phase control DNA replication speed and origin firing to preserve genomic stability. Such an S-phase function of p21 depends fully on its ability to displace partners from chromatin-bound proliferating cell nuclear antigen (PCNA). Vice versa, PCNA also regulates p21 by preventing its upregulation in the S phase, even in the context of robust p21 induction by γ irradiation. Such a tight regulation of p21 in the S phase unveils the potential that CDK-independent functions of p21 may have for the improvement of cancer treatments.
Overview
CoChat Summary
TL;DR
This review argues that p21 has CDK-independent, PCNA-dependent functions in S phase: residual p21 modulates DNA replication speed and origin firing, while p21 is actively degraded in S phase even after DNA damage. These S-phase functions may be relevant to cancer therapy, particularly through effects on translesion synthesis.
Key findings
- p21 is a 165-amino-acid protein; its C-terminal PCNA-binding region (aa139–164) contains a PIP degron with core QTSMTDFY (aa144–151). Flanking sequences contribute strongly: removing them drops PCNA affinity 10-fold, and replacing them with hydrophilic or negatively charged sequences reduces affinity by four orders of magnitude.
- In S phase, p21 remains at its lowest or undetectable levels and is not upregulated by γ irradiation, NCS, or nutlin-3; CRL4Cdt2 degrades PCNA-bound p21. Cellular p21/PCNA ratios reportedly never exceed 1:1, whereas blocking NER in vitro requires ≥10:1 and blocking replicative DNA synthesis in vitro requires 100:1, making direct inhibition of replicative polymerases by endogenous S-phase p21 unlikely.
- Residual S-phase p21 is a positive regulator of nascent DNA elongation: p21 downregulation impairs elongation and increases common fragile-site instability and micronuclei, via dysregulated pol κ loading onto PCNA. A separate report found p21 downregulation increased fork elongation, but both support that residual p21 controls replication speed.
- In p53-deficient models, p21 overexpression caused CDT1/CDC6/ORC upregulation, rereplication, asymmetric slow forks, and DSBs; p21–PCNA interaction prevented chromosome fusions and micronuclei. After UV, p21 downregulation permits TLS, whereas stable p21 blocks recruitment of pol η, κ, ι, and Rev1 and increases cell death and genomic instability.
Methods
- Narrative review; no primary experimental data. It synthesizes published literature on p21, PCNA, CDKs, DNA replication, DDR, TLS, and cancer therapy.
- Evidence discussed includes cell lines (e.g., MCF-7, SAOS-2, HCT116, Li-Fraumeni fibroblasts), C. elegans, live-cell imaging, single-cell analysis, in vitro binding/replication assays, and tumor marker colocalization; no systematic search or meta-analysis is described.
Limitations
- Stated: The review notes unresolved issues: whether cellular p21 levels suffice to displace replicative DNA polymerases from active replisomes; the mechanism by which S-phase p21–PCNA interaction triggers arrest outside S phase; inconclusive in vivo NER effects; and conflicting reports on whether p21 downregulation reduces or increases fork elongation, with different siRNAs and no p21-null models in one study.
- Evident: As a narrative review, it lacks a systematic search strategy, formal quality assessment, or quantitative synthesis; conclusions rely on selected literature and author interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Cell cycle imposes strong regulation on p21 levels in S phase. Levels of fluorescence-tagged p21, PCNA, and CDK activities presented by black, purple, and orange lines, respectively. Endogenous p21 levels not shown, as live image experiments focused on fluorescence-tagged p21. Only in G1 and G2 did p21 levels rise to an extent that could inhibit cyclin–kinase complexes such as CycE/CDK2. Since p21 levels in G1 are very heterogeneous, multiple black lines represent such dispersion in p21 expression. Length of the G1 phase correlates with p21 levels, which were higher than p21 levels in Phase G2 [16]. Whether p21 controls PCNA functions in G1 is still debated, but p21 overexpression levels, which are similar to highest levels reached by endogenous p21 after DNA damage, are not sufficient to modulate replicative DNA synthesis or nucleotide excision repair in G1 [51]. In S phase, levels of fluorescence-tagged p21 were undetectable both in unperturbed conditions and after γ-irradiation, nutlin-3, or neocarzinostatin (NCS) treatment, which are all well-characterized inducers of p21 [16,67,68]. These results indicate that excess of exogenous p21 is strongly prevented in the S phase. Either Cdt2 downregulation or the disruption of the PIP box of p21 allowed p21 upregulation in the S phase, indicating CRL4Cdt2 that degrades PCNA-bound p21, tightly controlling p21 levels in the S phase [16,67]. p21 represented as black linear and unstructured peptide; dotted p21 represent p21 degradation.](https://figures.cochat.ai/paper-figures/008b4a1d79af4057afa866d8b35c1c67/cdk-independent-and-pcna-dependent-functions-of-p21-in-dna-replication-figure-2.jpg)
![Figure 3 Alterations of endogenous p21 levels in S phase cause genomic instability. Endogenous p21 S normal levels are within the segmented gray box, interacting with PCNA in replication factories [79]. Such p21 levels are required to maintain genomic stability. Both positive and negative changes in p2l levels are detrimental to cell genomic stability. (bottom) Downregulation of p21 levels in S causes alterations in nascent DNA elongation speed in a manner that depends on p21–PCNA interaction [79,82]. Mechanism underlying the promotion of nascent DNA elongation by p21 involves the prevention of dysregulated loading of specialized polymerases to sites of DNA synthesis, favoring the utilization of processive polymerases on undamaged templates. Under such experiment settings, p21 downregulation causes genomic instability in a manner that depends on loss of p21–PCNA interaction [79]. The deaccelerating role of p21, oppositely, also depends on p21–PCNA interaction [82]. (top) While p53-proficient cells do not allow p21 upregulation in the S phase, p53-deficient cells escaping from a senescent-like phenotype allow DNA replication in the context of p21 overexpression. Increased p21 levels in the S phase saturate the CRL4Cdt2 E3 ligase, causing an upregulation of other CRL4Cdt2 targets involved in origin firing [71]. Alterations in replication choreography are followed by rereplication events and double-strand-break (DSB) accumulation that are channeled into error-prone repair, further fueling cell genomic instability [71,75].](https://figures.cochat.ai/paper-figures/44849e5b06254694a4cb09f5db5979ed/cdk-independent-and-pcna-dependent-functions-of-p21-in-dna-replication-figure-3.jpg)
![Figure 4 p21 overexpression in S phase triggers cell death by preventing DNA replication across DNA lesions. A) Endogenous p21 is degraded at sites of DNA lesions. Elimination of p21 [50] and concomitant ubiquitination of PCNA [24,98] promote loading of specialized DNA polymerases at forks stalled at DNA lesions [50]. In this way, p21 prevents loading such polymerases in undamaged templates [79], but when DNA lesions are encountered by replication forks, rapid CRLCdt2-mediated removal of p21 facilitates replication across DNA lesions (dotted p21 represents p21 degradation) [50]. B) When p21 degradation is prevented in the context of high PCNA ubiquitination, the recruitment of specialized polymerases to replication factories is impaired. Replicative polymerases stall persistently at DNA lesions, and forks collapse, triggering cell death and genomic instability [50]. Stable p21–PCNA interaction is essential for such a role of p21 in TLS inhibition.](https://figures.cochat.ai/paper-figures/9f1e606217e24e00824a06fb71ab50ca/cdk-independent-and-pcna-dependent-functions-of-p21-in-dna-replication-figure-4.jpg)
Verification
Claims the paper makes
22 Valid · 1 Not valid · 51 Not checked · 24 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“After γ irradiation, the CRLCdt2-dependent degradation of p21 was triggered by ATM (ataxia telangiectasia mutatated) activation [66].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 3. p21 Levels are Differentially Regulated during and by Cell Cycle
What the sources say
- Disputedcites [66] Stuart S.A. Wang J.Y. Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells J. Biol. Chem. 2009 284 15061 15070 10.1074/jbc.M808810200 19332548 PMC2685688 sourceExperimental — accuracy not yet measured
The Discussion says that ionizing-radiation-induced p21 degradation requires DDB1–Cdt2 but is independent of ATM. The Results report that inhibiting ATM did not prevent degradation and that degradation occurred with nearly identical kinetics in cells with and without ATM. Thus the cited paper contradicts the claim that ATM activation triggers the process. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 2. Can Cell-Cycle Arrest Be Achieved by p21–PCNA Interaction?
What the sources say
- Not checked yetcites [38] Luo Y. Hurwitz J. Massague J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 Nature 1995 375 159 161 10.1038/375159a0 7753174 source
- Not checked yetcites [39] Pan Z.Q. Reardon J.T. Li L. Flores-Rozas H. Legerski R. Sancar A. Hurwitz J. Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21 J. Biol. Chem. 1995 270 22008 22016 10.1074/jbc.270.37.22008 7665622 source
- Not checked yetcites [40] Shivji M.K. Ferrari E. Ball K. Hubscher U. Wood R.D. Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1 Oncogene 1998 17 2827 2838 10.1038/sj.onc.1202352 9879989 source
- Partly supportedcites [41] Cooper M.P. Balajee A.S. Bohr V.A. The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo Mol. Biol. Cell 1999 10 2119 2129 10.1091/mbc.10.7.2119 10397753 PMC25424 sourceExperimental — accuracy not yet measured
The Discussion reports that this study needed a p21:PCNA ratio of 50:1 for 50% inhibition of in vitro NER, so its own result exceeds 10:1. But it also reports that Pan et al. observed 50% inhibition at 3:1; the paper therefore does not establish 10:1 as a general minimum. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“After the initial loss of proliferation capacity, a fraction of p21-overexpressing cells evaded arrest/senescence, displaying upregulation of CDT1, CDC6, and ORC, which are all regulators of replication origin licensing [74].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 4. p21 Exerts Specific Functions at S-Phase-Specific Level, Regulating Genomic Stability through PCNA Interaction
What the sources say
- Supportedcites [74] Duzdevich D. Warner M.D. Ticau S. Ivica N.A. Bell S.P. Greene E.C. The dynamics of eukaryotic replication initiation: Origin specificity, licensing, and firing at the single-molecule level Mol. Cell 2015 58 483 494 10.1016/j.molcel.2015.03.017 25921072 PMC4427541 source
The citation follows the clause identifying CDT1, CDC6, and ORC as regulators of replication origin licensing, not the preceding observation about p21-overexpressing cells. The Results section, “Mcm2-7 Loading Occurs Preferentially at ARS1” (page unavailable), describes Mcm2-7/Cdt1 in loading reactions and states that loading depends on ORC and Cdc6; the Discussion explicitly addresses Mcm2-7/Cdt1 recruitment and origin licensing. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The dependency on PCNA was confirmed using a p21 mutant with a disrupted PIP box (Q144A, M147A, and F150A), which did not cause CDT1 and CDC6 upregulation [71].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 4. p21 Exerts Specific Functions at S-Phase-Specific Level, Regulating Genomic Stability through PCNA Interaction
What the sources say
- Partly supportedcites [71] Galanos P. Vougas K. Walter D. Polyzos A. Maya-Mendoza A. Haagensen E.J. Kokkalis A. Roumelioti F.M. Gagos S. Tzetis M. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing Nat. Cell Biol. 2016 18 777 789 10.1038/ncb3378 27323328 PMC6535144 sourceExperimental — accuracy not yet measured
The Results subsection 'p53-independent stimulation of p21WAF1/Cip1 up-regulates key replication licensing factors' states that a mutant p21WAF1/Cip1 with three substitutions in its PIP degron motif, abrogating PCNA interaction (required for CRL4CDT2 targeting), 'did not augment Cdt1 expression', favouring the saturation/competition mechanism (Fig. 2b); the Material and Methods ('siRNA transfections and retrovirus infections') identify the mutant p21PCNA as carrying Q144, M147, F150 → A substitutions, so the PIP-box residue detail and the CDT1 part are supported. However, our copy never reports that this PCNA-binding-defective mutant failed to up-regulate CDC6 — Cdc6 is discussed as stabilized in p21WAF1/Cip1-expressing cells via reduced Cdh1/Fzr1 and Cdk2-mediated Ser54 phosphorylation (Supplemental Fig. S5c), and the only mutant result cited there is reduced re-replication/DNA damage (Supplemental Fig. S5,S9). The CDC6 element of the claim is therefore not attributed to this source. (LLM, conf=0.78)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Because both rereplication and error-prone DSB repair fuel genomic instability, these observations indicate a pro-oncogenic role of p21, at least in p53-negative cancer [71,75].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 4. p21 Exerts Specific Functions at S-Phase-Specific Level, Regulating Genomic Stability through PCNA Interaction
What the sources say
- Supportedcites [71] Galanos P. Vougas K. Walter D. Polyzos A. Maya-Mendoza A. Haagensen E.J. Kokkalis A. Roumelioti F.M. Gagos S. Tzetis M. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing Nat. Cell Biol. 2016 18 777 789 10.1038/ncb3378 27323328 PMC6535144 source
The Discussion (page not available in our copy) explicitly describes p21 as capable of oncogenic activity and identifies p53 inactivation as the factor that shifts it toward that role. It also links p21-associated rereplication and lower-fidelity repair to genomic instability, supporting the citing sentence’s rationale. (LLM, conf=0.94)
- Supportedcites [75] Galanos P. Pappas G. Polyzos A. Kotsinas A. Svolaki I. Giakoumakis N.N. Glytsou C. Pateras I.S. Swain U. Souliotis V.L. Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability Genome Biol. 2018 19 37 10.1186/s13059-018-1401-9 29548335 PMC5857109 source
The Conclusions state that chronic p53-independent p21 expression causes genome re-replication and error-prone repair of double-strand breaks, thereby fueling genomic instability and promoting cancer development. This supports the claimed pro-oncogenic role in the stated p53-negative context. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
69 more claims · 15 with their cited sources checked
Create a free account to see all 98 claims and to verify the 84 references still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“p21 strongly binds this DNA replication factor via a canonical PCNA-interacting protein box motif (53).”
From A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21 (2023) · cites this paper as [53]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The origin of SASP factors can be traced using histological methods; however, secreted factors are normally small proteins poorly retained within cells, which makes their detection using IHC/IHF highly challenging, although there has been some success, for example, with IHC against IL-1α29 and IL-1β30.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 3. p21 Levels are Differentially Regulated during and by Cell Cycle
“After γ irradiation, the CRLCdt2-dependent degradation of p21 was triggered by ATM (ataxia telangiectasia mutatated) activation [66].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > References
“66. Stuart S.A. Wang J.Y. Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells”
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 1×
“p21 is also essential for the prevention of endoreduplication and induction of senescence after extended cell-cycle arrest [18,19].”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 2×
“All defects observed when p21 is downregulated were phenocopied in HCT116 cells in which p21 was stably knocked out [14,79].”
Backgroundp21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · cited 2×
“Since SCFSkp2 degrades cyclin–CDK-bound p21 [1], it is possible that the main signal forcing p21 degradation in the S phase is associated with an E3 ligase that is active beyond the G1/S boundary.”
BackgroundMice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655 · cited 1×
“Intriguingly, the expression of a p21 mutant with a disrupted PCNA-binding domain (Q144A, M147A, and F150A [71]) caused arrest in G1 after γ-irradiation [67], suggesting that p21–PCNA interaction prevented rather than promoted cell-cycle arrest, as originally postulated based on its ability to displace replicative DNA…”
BackgroundNew functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1×
“High p21 levels trigger arrest in Phases G1 and G2 of the cell cycle [5,14,15].”
BackgroundCDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152 · cited 1×
“While CDK inhibition prevents the initiation of DNA replication [32], the interaction of p21 with PCNA at replisomes would block the cell cycle after the initialization of the S phase.”
Background
Cited by
Guidelines for minimal information on cellular senescence experimentation in vivo
Ogrodnik, M., Carlos Acosta, J., Adams, P. D., d’Adda di Fagagna, F., Baker, D. J., Bishop, C. L., Chandra, T., Collado, M., Gil, J., Gorgoulis, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.059 · Cited by 376
Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets
Luan, Y., Zhu, X., Jiao, Y., Liu, H., Huang, Z., Pei, J., Xu, Y., Yang, Y., & Ren, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01792-5 · Cited by 122
“It binds to caspases to suppress cellular apoptosis, inducing cell senescence [69].”
BackgroundRegulation of substrate utilization and adiposity by Agrp neurons
Cavalcanti-de-Albuquerque, J. P., Bober, J., Zimmer, M. R., & Dietrich, M. O. (2019) · Nature Communications · doi:10.1038/s41467-018-08239-x · Cited by 100
Wang, Y., Chu, F., Lin, J., Li, Y., Johnson, N. L., Zhang, J., Gai, C., Su, Z., Cheng, H.-J., Wang, L., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114399 · Cited by 95
CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?
Manousakis, E., Miralles, C. M., Esquerda, M. G., & Wright, R. H. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417488 · Cited by 83
“In fact, endogenous levels of CDKN1A/p21 are insufficient to block DNA replication in the S-phase [77].”
BackgroundTicli, G., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137058 · Cited by 76
“The evidence that the orderly degradation of p21, in a way similar to the S phase, also occurs after DNA damage [143] suggests that p21 regulates DNA repair and that this activity must be performed before its degradation [142].”
BackgroundInfluentialDeng, S., Vlatkovic, T., Li, M., Zhan, T., Veldwijk, M. R., & Herskind, C. (2022) · Cancers · doi:10.3390/cancers14194874 · Cited by 62
“Stable p53 stimulates transcription of the downstream gene CDKN1A coding for the CDK inhibitor p21, which binds and further represses the cyclin E/CDK2 and cyclin A/CDK2 complexes, leading to the G1/S arrest [31,32].”
Backgroundp21 can be a barrier to ferroptosis independent of p53
Venkatesh, D., Stockwell, B. R., & Prives, C. (2020) · Aging · doi:10.18632/aging.103961 · Cited by 55
“The inhibitory effect of p21 on CDKs mediates its effect on the different cell cycle stages, whereas its abrogation of the role of PCNA mediates its ability to block damaged-DNA replication [37].”
BackgroundLai, L., Shin, G. Y., & Qiu, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228504 · Cited by 58
“This motif is indispensable for the inhibition property of p21Cip1/Waf1, which allows p21Cip1/Waf1 binding to CDK in a region that blocks its ability to complex with cyclins, and thus prevents CDK activation [26,27].”
BackgroundIcariside II: Anticancer Potential and Molecular Targets in Solid Cancers
Xu, F., Wu, Q., Li, L., Gong, J., Huo, R., & Cui, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.663776 · Cited by 49
Lin, X., Xia, L., Zhou, Y., Xie, J., Tuo, Q., Lin, L., & Liao, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094240 · Cited by 63
Xiao, H. F., Ye, X., Vishwakarma, V., Preet, R., & Dixon, D. A. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2034455 · Cited by 40
Yang, Y., Li, H., Zuo, J., & Lei, F. (2025) · JOR Spine · doi:10.1002/jsp2.70089 · Cited by 41
“The CDK cyclin complex's activity is suppressed when p21 attaches to CDKs, stopping the cell cycle and causing cells to stop at a particular stage, typically G1 or G2 [38, 39].”
Chang‐Chien, J., Huang, J., Tsai, H., Wang, S.-L., Kuo, M., & Yao, T. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112484 · Cited by 39
A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis
Gueiderikh, A., Maczkowiak, F., & Rosselli, F. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100904 · Cited by 41
Wong, C. J. K., Tai, Y. K., Yap, J. L. Y., Fong, C. H. H., Loo, L. S. W., Kukumberg, M., Fröhlich, J., Zhang, S., Li, J., Wang, J., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121658 · Cited by 37
“By contrast, the expression levels of p21, a cyclin-dependent kinase (CDKs) inhibitor [37], were instead reduced by downward magnetic fields and unaltered by upward field exposure (Fig.”
BackgroundCDT1 inhibits CMG helicase in early S phase to separate origin licensing from DNA synthesis
Ratnayeke, N., Baris, Y., Chung, M., Yeeles, J. T. P., & Meyer, T. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.004 · Cited by 38
“Time (h) Origin firing CRL4Cdt2 mCherry hCDT1(1-100)ΔCy C-CRL4Cdt2 reporter QIBC”
Hassan, A. A., Moustafa, E. M., EL-Khashab, I. H., & Mansour, S. Z. (2021) · Dose-Response · doi:10.1177/15593258211025190 · Cited by 35
“DNA damage and stress signals may induce the activation of p53 protein, which has 3 major roles in DNA repair, apoptosis and growth arrest by suppressing PCNA.(49) On the other hand, Sheng et al(50) stated that the disrupted PCNA binds with p21 mutant caused arrest in G1 after-irradiation, suggesting that p21-PCNA int…”
BackgroundInfluentialInterplay between the DNA damage response and the life cycle of DNA tumor viruses
Studstill, C. J., Mac, M., & Moody, C. A. (2023) · Tumour Virus Research · doi:10.1016/j.tvr.2023.200272 · Cited by 32
“KDM6A epigenetically de-represses p21 expression through the removal of repressive H3K27me3 marks. p21 suppresses replication stress by binding to PCNA and inhibiting cellular DNA replication [75].”
BackgroundBiber, S., Pospiech, H., Gottifredi, V., & Wiesmüller, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa974 · Cited by 27
Self-citationNeural Progenitor Cells and the Hypothalamus
Makrygianni, E. A., & Chrousos, G. P. (2023) · Cells · doi:10.3390/cells12141822 · Cited by 33
“PCNA is upregulated during the G1 and S phases of the cell cycle and downregulated during the cell transition into the G2 and M phases; however, PCNA can also be detected in the early G0 phase [133].”
BackgroundFOXO1 regulates bovine skeletal muscle cells differentiation by targeting MYH3
Jiang, C. Q., Zhang, J., Song, Y., Song, X., Wu, H., Jiao, R., Li, L., Zhang, G., & Wei, D. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129643 · Cited by 26
Impact of the interplay between stemness features, p53 and pol iota on replication pathway choices
Ihle, M., Biber, S., Schroeder, I. S., Blattner, C., Deniz, M., Damia, G. L. M., Gottifredi, V., & Wiesmüller, L. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab526 · Cited by 25
Self-citationYang, S. F., Nelson, C. B., Wells, J., Fernando, M., Lu, R., Allen, J. A. M., Malloy, L., Lamm, N., Murphy, V. J., Mackay, J. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46578-0 · Cited by 23
Rahmani, F., Zandigohar, M., Safavi, P., Behzadi, M., Ghorbani, Z., Payazdan, M., Ferns, G. A., Hassanian, S. M., & Avan, A. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230306123455 · Cited by 21
Fromell, K., Johansson, U., Abadgar, S., Bourzeix, P., Lundholm, L., & Elihn, K. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105586 · Cited by 18
p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway
Guo, Y., Rall-Scharpf, M., Bourdon, J., Wiesmüller, L., & Biber, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04224-3 · Cited by 16
Hypoxia-Induced ZWINT Mediates Pancreatic Cancer Proliferation by Interacting With p53/p21
Chen, P., He, Z., Wang, J., Xu, J., Jiang, X., Chen, Y., Liu, X., & Jiang, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.682131 · Cited by 16
Qin, X., Chen, X., Guo, L., Liu, J., Yang, Y. B., Zeng, Y., Li, C., Liu, W., & Ma, W. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03580-7 · Cited by 16
“Cyclin B1/Cdc2 complex is a key regulator of mitotic entry, and its activity determines whether cells enter mitosis or arrest at G2 phase [28].”
BackgroundChang, S., Ren, D., Zhang, L., Liu, S., Yang, W., Cheng, H., Zhang, X., Hong, E., Geng, D., Wang, Y., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217120 · Cited by 15
RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer
She, X., Lin, Y., Liang, R., Liu, Z., Gao, X., & Ye, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s278755 · Cited by 16
Xi, Y., Wen, X., Zhang, Y., Jiao, L., Bai, S., Shi, S., Chang, G., Wu, R., Sun, F., Hao, J., et al. (2022) · Aging and Disease · doi:10.14336/ad.2021.1104 · Cited by 16
“As an important member of the cyclin-dependent kinase inhibitor family, p21 can not only inhibit the expression of cyclin-dependent kinases (CDKs) [41] but also regulate the expression of PCNA.”
BackgroundEvidence-Based Management of Uterine Fibroids With Botanical Drugs-A Review
Arip, M., Yap, V. L., Rajagopal, M. S., Selvaraja, M., Dharmendra, K., & Chinnapan, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878407 · Cited by 26
“On the other hand, PCNA is essential for cell proliferation, and it interacts with various proteins in regulating the cell cycle, DNA replication, and DNA repair process (Mansilla et al., 2020).”
BackgroundHong, W., Gong, P., Pan, X., Liu, Y., Qi, G., Qi, C., & Qin, S. (2023) · Brain Pathology · doi:10.1111/bpa.13186 · Cited by 14
“It has been proposed that p21 directly binds to cyclin-dependent kinase (CDK)—cyclin complexes to inhibit their catalytic activity and induce cell cycle arrest [54].”
BackgroundHu, H., Chen, J., Zhang, F., Sheng, Z., Yang, Y., Xie, Y., Zhou, L., & Liu, Y. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01026 · Cited by 14
Zhang, T., Gu, H.-W., Gao, J.-X., Li, Y.-S., & Tang, H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114917 · Cited by 14
Hu, H.-F., Wang, Z., Tang, W., Fu, X.-M., Kong, X., Qiu, Y., & Xi, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1047507 · Cited by 14
“PCNA, a nuclear protein synthesized in G1 and S phases of the cell cycle, is used as a biomarker to monitor changes to cell growth (Mansilla et al., 2020).”
BackgroundZhou, X., Chen, A., & Zhang, T. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11892 · Cited by 14
Xu, Y., & Yang, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1194865 · Cited by 18
Midazolam alleviates cellular senescence in SH‐SY5Y neuronal cells in Alzheimer's disease
Wang, P., Wang, P., Luan, H., Wu, Y., & Chen, Y. (2022) · Brain and Behavior · doi:10.1002/brb3.2822 · Cited by 13
UTP18-mediated p21 mRNA instability drives adenoma-carcinoma progression in colorectal cancer
Pan, M., Xiao, T., Xu, L., Xie, Y., & Ge, W. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112423 · Cited by 14
The mechanism of EGF in promoting skeletal muscle post-injury regeneration
Teng, H., Liu, Y., Hao, R., Zhang, L., Zhang, X., Li, S., Li, S., & Tong, H. (2025) · Differentiation · doi:10.1016/j.diff.2025.100862 · Cited by 12
LINC00324 in cancer: Regulatory and therapeutic implications
Xia, Q., Shen, J., Wang, Q., Ke, Y., Yan, Q., Li, H., Zhang, D., & Duan, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1039366 · Cited by 13
Mechanisms and therapeutic strategies linking mesenchymal stem cells senescence to osteoporosis
Tong, Y., Tu, Y., Wang, J., Liu, X., Su, Q., Wang, Y., & Wang, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1625806 · Cited by 19
Montero, L., Okraine, Y. V., Orlowski, J., Matzkin, S., Scarponi, I., Miranda, M. V., Nusblat, A. D., Gottifredi, V., & Alonso, L. G. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.013 · Cited by 11
Self-citationKumar, S., Maurya, V. K., Chitti, S. V., Kabir, R., Shanker, K., Nayak, D., Khurana, A. K., Manchanda, R. K., Gadugu, S., Kumar, V., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00209 · Cited by 11
Velli, S. K., Sundaram, J., Sharmila, S., Palanisamy, K., Nirmala, S., & Devaki, T. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14366 · Cited by 12
Jiang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112937 · Cited by 17
“The stable p21-PCNA interaction is important for p21 in TLS inhibition [114].”
BackgroundState of the Art of Pharmacological Activators of p53 in Ocular Malignancies
Casciano, F., Zauli, E., Busin, M., Caruso, L., Al-Mesfer, S., Al-Swailem, S. A., Zauli, G., & Yu, A. C. (2023) · Cancers · doi:10.3390/cancers15143593 · Cited by 11
“In addition, p21, which is a 21 kDa protein also known as WAF1, acts as a potent cyclin-dependent kinase 4 (CdK4)/cyclin D1 complex inhibitor essential for inducing cell cycle arrest mediating the downregulation of G1/S genes [68] and halting the cell cycle in the S and G2 phases in response to DNA damage [69].”
BackgroundLing, J.-Y., Wang, Q.-L., Liang, H.-N., Liu, Q., Yin, D.-H., & Li, L. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3679-4 · Cited by 11
Ma, Z., Deng, X., Li, R., Hu, R., Miao, Y., Xu, Y., Zheng, W., Yi, J., Wang, Z., Wang, Y., et al. (2022) · Veterinary Microbiology · doi:10.1016/j.vetmic.2022.109414 · Cited by 10
Zhang, W., Yang, F., Yan, Q., Li, J., Zhang, X., Jiang, Y., & Dai, J. (2023) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2023.09.006 · Cited by 13
Ali, M. K., Stone, D., Laknaur, A., Yang, Q., & Al-Hendy, A. A. (2023) · F&S Science · doi:10.1016/j.xfss.2023.05.003 · Cited by 14
Effects of weaning on intestinal longitudinal muscle-myenteric plexus function in piglets
Li, J., Liu, F., Mo, K., Ni, H., & Yin, Y. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2391-x · Cited by 10
“Elevated p53 was reported to induce G1 or G2 arrest and increase apoptosis (Nag et al., 2013). p21 has high molecular activity, and it can bind to cyclin D/E/A/B and cyclin-dependent kinases to regulate the cell cycle (Mansilla et al., 2020).”
Bélanger, F., Roussel, C., Sawchyn, C., St-Hilaire, E., Gezzar-Dandashi, S., Kimenyi Ishimwe, A. B., Mallette, F. A., Wurtele, H., & Drobetsky, E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104900 · Cited by 9
“Indeed, p21 strongly binds this DNA replication factor via a canonical PCNA-interacting protein box motif (53).”
BackgroundCircular RNA Controls Tumor Occurrence and Development via Cell Cycle Regulation
Liu, F., Qu, R., Yang, L., Shi, G., Hao, S., & Hu, C. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s371629 · Cited by 11
“In addition, the p21 gene can be activated by p53.(85,86) Notably, a previous study reported that circMTO1 was significantly downregulated in HCC.”
BackgroundSuman, I., Jezidžić, A., Dobrić, D., Višnić, A., & Domitrović, R. (2025) · Biology · doi:10.3390/biology14050527 · Cited by 11
“The interplay between p21 and PCNA is complex, but the most accepted function of PCNA is the control of DNA replication by interaction with p21 [35].”
Fu, Y., Huang, R., Li, J., Xie, X., & Deng, Y. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1923727 · Cited by 9
“:3 significantly downregulated Cyclin D1 that drives cell-cycle progression via binding to cyclin-dependent kinases4 (CDK4) (29), and upregulated p21 that mediates cell-cycle arrest by inhibiting the action of G1 CDK (30), at mRNA level.”
BackgroundHuang, R., Nie, W., Mi, L., Yao, C., & Zhu, H. (2024) · Aging · doi:10.18632/aging.205759 · Cited by 7
“Additionally, P21 expression acts as a suppressor of tumor growth [45] and exhibits specific functions during the S-phase, regulating genomic stability through its interaction with PCNA [46].”
Dropmann, A., Alex, S., Schorn, K., Tong, C., Caccamo, T., Godoy, P., Ilkavets, I., Liebe, R., Gonzalez, D., Hengstler, J. G., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150409 · Cited by 9
Shan, Y., Zheng, L., Zhang, S., & Qian, B. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149251 · Cited by 7
Simonsen, S., Larsen, F. B., Søgaard, C. K., Jonsson, N., Lindorff‐Larsen, K., Bruheim, P., Otterlei, M., Hartmann‐Petersen, R., & Kragelund, B. B. (2025) · The FEBS Journal · doi:10.1111/febs.70133 · Cited by 7
“It is a potent cyclin-dependent kinase inhibitor (CDKI) functioning as a regulator of cell cycle progression [34] facilitated by the binding of p21 to cyclin-CDK complexes through its N-terminal domain [35 – 37]. p21 also plays a regulatory role in DNA replication and DNA damage repair and binds to…”
Vignesh, A., Dharani, K., Selvakumar, S., & Vasanth, K. (2024) · 3 Biotech · doi:10.1007/s13205-024-04167-4 · Cited by 9
“Nonetheless, advanced computational techniques present new opportunities to address this issue (Mansilla et al. 2020).”
Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer—A Comprehensive Review of Literature
Kciuk, M., Wanke, K., Marciniak, B., Kołat, D., Aleksandrowicz, M., Mujwar, S., Ainane, T., & Kontek, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031152 · Cited by 9
Rodak, O., Mrozowska, M., Rusak, A., Gomułkiewicz, A., Piotrowska, A., Olbromski, M., Podhorska‐Okołów, M., Ugorski, M., & Dzięgiel, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411316 · Cited by 6
Ren, G., Ren, G., Chen, J., Pu, Y., Yang, E. J., Tao, S., Mou, P. K., Chen, L.-J., Zhu, W., Chan, K. L., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91867 · Cited by 8
“In contrast, cytoplasmic p21 functions as an oncogene by promoting cyclin/CDK complex and inhibiting apoptosis [9].”
BackgroundJia, X., Zhao, Y., Li, Q., Lu, X., Wang, X., Wang, H., Shi, Z., Xu, Y., Huang, B., Huang, F., et al. (2024) · Journal of Breast Cancer · doi:10.4048/jbc.2024.0063 · Cited by 8
Fan, Y., Li, X., Li, Q., Zhou, L., He, J., Lei, H., & Su, J. (2021) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2021.109131 · Cited by 6
Correlation between HPV PCNA, p16, and p21 Expression in Lung Cancer Patients
Marcos, B. D. F. S., de Oliveira, T. H. A., do Amaral, C. M. M., Muniz, M. T. C., & de Freitas, A. C. (2022) · Cellular Microbiology · doi:10.1155/2022/9144334 · Cited by 7
“In the same way, PCNA-augmented expression would exert a feedback reaction and increase p21 expression [60].”
BackgroundJung, M.-S., Kim, W., Cho, J. W., Yang, W. H., & Chung, I. K. (2022) · Biochemical Journal · doi:10.1042/bcj20220391 · Cited by 9
The VGLL2 gene participates in muscle development in Gushi chickens1
Li, W., Hao-xiang, M. A., Wang, Y., ZHANG, Y.-S., Liu, Y., Rui-li, H. A. N., Hong, L. I., Han-fang, C. A. I., Xiao-jun, L. I. U., Kang, X., et al. (2023) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2023.06.017 · Cited by 11
Kuczak, M., Cieślik, W., Musioł, R., & Mrozek‐Wilczkiewicz, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-79698-0 · Cited by 5
Qi, M., He, P., Zhang, L., & Dong, W. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i8.893 · Cited by 5
p21/Zbtb18 repress the expression of cKit to regulate the self-renewal of hematopoietic stem cells
Wang, N., Yang, S., Li, Y., Gou, F., Lv, Y., Zhao, X., Wang, Y., Xu, C., Zhou, B., Dong, F., et al. (2024) · Protein & Cell · doi:10.1093/procel/pwae022 · Cited by 5
“Due to this fundamental nature, p21 can interact with various targets, including transcription factors and kinases, to perform a wide range of critical biological functions (Dutto et al., 2015; Georgakilas et al., 2017; Karimian et al., 2016; Kreis et al., 2019; Mansilla et al., 2020).”
BackgroundInfluentialNew link between RNH1 and E2F1: regulates the development of lung adenocarcinoma
Zhao, W., Liu, Y., Yang, Y., & Wang, L. (2024) · BMC Cancer · doi:10.1186/s12885-024-12392-6 · Cited by 6
“PCNA is a marker of early LUAD [34] and p21 is a suppressor of CDK that indirectly inhibits cell cycle and proliferation [35].”
BackgroundContribution of p53-dependent and -independent mechanisms to upregulation of p21 in Fanconi anemia
Renaudin, X., Nachar, B. A. A., Mancini, B., Gueiderikh, A., Louis-Joseph, N., Maczkowiak, F., & Rosselli, F. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011474 · Cited by 5
Sirotkin, A. V., Fabová, Z., Aldahmash, W., Alshamrani, A., & Harrath, A. H. (2023) · Physiological Research · doi:10.33549/physiolres.935060 · Cited by 5
Calzetta, N. L., Mansilla, S. F., Ahlers, C. M., Bertolin, A. P., Caimi, L. I., Arbilla, S. V., Zeng, J., Wiesmüller, L., & Gottifredi, V. (2025) · Science Advances · doi:10.1126/sciadv.adw4618 · Cited by 6
“While p21 encodes the strongest PIP box, replicative Pols have a multisubunit organization with multiple PIPs that may prevent their displacement from the PCNA trimer (with three docking sites for PIPs) by p21 ( 58 ).”
Self-citationRiutin, M., Erez, P., Adler, J., Biran, A., Myers, N., & Shaul, Y. (2024) · Cells · doi:10.3390/cells13191670 · Cited by 3
“At its N-terminus, p21 forms complexes with CDK1, CDK2, CDK3, CDK4, and CDK6 along with specific cyclins associated with these kinases [4,8,9].”
BackgroundGupta, S. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00682-7 · Cited by 5
“Knockout of p21 accelerates replication fork collapse and chromosomal aberrations following genotoxic stress, whereas enforced expression delays replication but allows more ef fi cient lesion repair 19 .”
Study on the Effects and Mechanism of Corilagin on A2780 Cell Apoptosis
Xu, Z., Jiang, Y., Shan, T., Hu, L., Wu, M., Ji, H., Li, L., Yi, Y., Wang, H., & Wang, L. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020105 · Cited by 3
Mucignat, G., Bassan, I., Giantin, M., Pauletto, M., Bardhi, A., Iori, S., Lopparelli, R. M., Barbarossa, A., Zaghini, A., Novelli, E., et al. (2022) · Toxins · doi:10.3390/toxins14070435 · Cited by 3
Cheng, Z., Zhang, Y., Yang, Z., Fan, J., Xu, Y., Li, M., Chen, H., & Zhou, L. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07304-5 · Cited by 2
“PCNA is highly expressed in the S phase of the cell cycle and is an important node for cell inspection [31, 32].”
BackgroundPEAR1 Promotes Myoblast Proliferation Through Notch Signaling Pathway
Zhao, Y., Zhang, L., Hao, R., Li, S., Li, S., Shi, S., Tong, H., & Liu, B. (2024) · Biology · doi:10.3390/biology13121063 · Cited by 2
DMF, an activator of Nrf2, could mitigate cholic-acid-induced liver damage in high-fat diet
Abu-Halaka, D., Rauchbach, E., Zeigerman, H., & Tirosh, O. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100581 · Cited by 2
Guo, X., Zhang, S., Sun, Q., Li, H., & Wang, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1627412 · Cited by 4
“The molecular pathways regulated by p16INK4a/Rb and p53/p21 are pivotal in cellular senescence (52). p16, encoded by the CDKN2A gene, inhibits cell cycle progression and is closely associated with senescence (53). p21 negatively regulates the cell cycle by inhibiting CDK activity (54).”
Krejčíř, R., Arcimowicz, Ł., Hároníková, L., Hrabal, V., Kokas, F. Z., Henek, T., Kucerikova, M., Bonczek, O., Zatloukalová, P., Hernychová, L., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70143 · Cited by 3
Lee, J. H., Ko, Y. S., Eom, Y. S., & Kim, S. J. (2025) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2025.42.69 · Cited by 2
“PCNA is a key protein in DNA replication, interacting with DNA polymerases δ and ε, replication factor C, and the Cdc45/ Mcm2-7/GINS complex to facilitate DNA synthesis [28].”
Tang, W., Cao, J., Wang, N., Tang, L., & Cao, J. (2025) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s554181 · Cited by 2
“39,40 EZH2 suppresses p21 expression via H3K27me3 modification, facilitating the G1/S phase transition and enabling continuous proliferation even under genotoxic stress.”
Xia, Q., Chen, C., Dopman, E. B., & Hahn, D. A. (2023) · Journal of Experimental Biology · doi:10.1242/jeb.245244 · Cited by 2
The Bombyx mori G protein β subunit 1 (BmGNβ1) gene inhibits BmNPV infection
Yu, L., Ling, C., Li, Y., Guo, H., Xu, A., Qian, H., & Li, G. (2024) · Journal of Invertebrate Pathology · doi:10.1016/j.jip.2024.108097 · Cited by 2
Rashidi, A., Füchtbauer, E., Vahabzadeh, Z., Soleimani, F., Rahimi, K., Nikkhoo, B., Fakhari, S., Erfan, M. B. K., Azarnezhad, A., Pooladi, A., et al. (2024) · Biochemical Engineering Journal · doi:10.1016/j.bej.2024.109553 · Cited by 2
CCNG1 oncogene: a novel biomarker for cancer therapy /gene therapy
Gordon, E. M., Ravicz, J. R., Chawla, S. P., Szeto, C. W., Chawla, S. P., Morse, M. A., Hall, F. L., & Gordon, E. M. (2021) · Cancer Research and Cellular Therapeutics · doi:10.31579/2640-1053/090 · Cited by 2
“showed that Cyclin G1 was triggered to cluster in a discrete nuclear pattern at DNA replication foci; demonstrating subcellular co-localizing at foci containing the replicationassociated proliferating cell nuclear antigen (PCNA), which physically binds to the classic CDKN1A/ p21-tumor suppressor [32], to regulate geno…”
BackgroundLong, T. T., Phuong, L. T., Dang, L. V. N., Ngoc, T. T. B., Thảo, Đ. T. P., & Trinh, N. T. M. (2025) · 3 Biotech · doi:10.1007/s13205-025-04214-8 · Cited by 3
“Furthermore, p21 has been shown to inhibit DNA synthesis (Abukhdeir and Park 2008) through interaction with PCNA and replication factors such as DNA polymerase δ (Mansilla et al. 2020).”
Cui, H. S., Zheng, Y., Cho, Y. S., Ro, Y. M., Kwak, I. S., Joo, S. Y., & Seo, C. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125876 · Cited by 2
“The signaling molecules downstream of AKT include cell cycle regulators, such as p21 and p27 [20]. p21 serves as a cell cycle checkpoint (R-point) and induces cell cycle arrest [23].”
Hetrick, Y. M., Fesseha, M., & Hong, M. Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104667 · Cited by 1
Lei, X., Feng, Z., Wang, X., & He, X. (2020) · doi:10.21203/rs.3.rs-37567/v1
Luo, Y., Xu, J., Zhou, M., Lei, X., Cao, W., Wang, X., & Qiao, R. (2021) · Research Square · doi:10.21203/rs.3.rs-37567/v2
Bélanger, F., Roussel, C., Sawchyn, C., Gezzar-Dandashi, S., Ishimwe, A. B. K., Mallette, F. A., Würtele, H., & Drobetsky, E. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.14.488378
Ferroptosis-related genes are involved in the activity of resveratrol against esophageal cancerPreprint
Chen, X., Chen, H., Hu, P., Lin, Y., Zou, Z., & Chen, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3275654/v1
Metadata
- Authors
- Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V.
- Affiliations
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Cell Cycle and Genomic Stability Laboratory, Fundación Instituto Leloir, IIBBA-CONICET, Av. Patricias Argentinas 435, Buenos Aires 1405, Argentina
- Corresponding author
- Gottifredi, Vanesa
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2020-05-28
- Volume
- 11
- Issue
- 6
- Pages
- 593
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC7349641
- OpenAlex
- W3030260166
- Semantic Scholar
- 1a60fb98d0bf4fd8673c22ae4a9ffbd4266624fd
- Cited by
- 114
- References
- 125
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 22 · 2023: 22 · 2022: 20 · 2021: 16 · 2020: 5
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Funders
- Agencia Nacional de Promoción Científica y Tecnológica (PICT 2016- 1239, PICT 2017-0612)
- Instituto Nacional del Cáncer (No grant number)
- Ben Barres spotlight award from eLIFE (No grant number)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, DNA replication, cyclin-dependent kinases, PCNA, S phase, origin firing, genome stability, p53, cell cycle arrest, chromatin binding, cancer therapy
- MeSH terms
- DNA Replication, Humans, S Phase, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Protein Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.